Rackliffe Philip, GE HealthCare Technologies’ CEO, AIS, forfeited 856 shares at $71.23 per share. After the transactions on 2026-09-01, his reported ownership stood at 42,331 shares, giving investors the updated holding associated with the executive’s share activity.
Key Highlights
- Rackliffe Philip’s post-transaction ownership was 42,331 GE HealthCare Technologies shares.
- The share forfeiture occurred on 1 September 2026.
- Rackliffe Philip forfeited 856 shares across three separate transactions as the AIS chief executive.
GE HealthCare Technologies Inc. (NASDAQ: GEHC) reported that Rackliffe Philip, its CEO, AIS, forfeited 856 shares at $71.23 per share. After the transactions, Philip’s ownership stood at 42,331 shares. The action took place on 1 September 2026. The 856-share total was spread across three separate transactions, with the shares assigned the same $71.23 per-share value.
$71.23 Share Forfeiture and 42,331-Share Ownership
The reported activity involved 856 GE HealthCare Technologies Inc. shares forfeited by Philip. The forfeited shares were valued at $71.23 per share. The transaction date was 1 September 2026, and the post-transaction holding was 42,331 shares.
FAQs
Q: How many GE HealthCare shares did Rackliffe Philip forfeit?
A: Rackliffe Philip forfeited 856 GE HealthCare Technologies shares. The shares were assigned a value of $71.23 per share in the transaction activity.
Q: How many shares did the GE HealthCare CEO own afterward?
A: After the three transactions, Rackliffe Philip owned 42,331 GE HealthCare Technologies shares. The filing identifies him as GE HealthCare Technologies Inc.’s CEO, AIS.
Q: When did the GE HealthCare share forfeiture occur?
A: The forfeiture occurred on 1 September 2026, according to the filing. It covered 856 GE HealthCare Technologies shares across three transactions, with each transaction reported at $71.23 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.